DiabetesTeam

While the search results don't specifically address Levemir's discontinuation, it's worth noting that the insulin market is evolving with new biosimilar options becoming available. These biosimilar insulins are designed to work the same way as brand-name versions, with no meaningful differences in safety or effectiveness.

Show Full Answer

While the search results don't specifically address Levemir's discontinuation, it's worth noting that the insulin market is evolving with new biosimilar options becoming available. These biosimilar insulins are designed to work the same way as brand-name versions, with no meaningful differences in safety or effectiveness.

If you're concerned about accessing your insulin, speak with your healthcare provider about alternative long-acting insulin options. They can help determine the best replacement that matches your current treatment needs and lifestyle. The good news is that there are several insulin options available, including biosimilar products that may be more affordable. When switching to a new insulin, your healthcare provider will help ensure the transition is smooth and that your blood sugar management remains stable.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

First Fast-Acting Insulin Biosimilar Could Lower Diabetes Treatment Costs